Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- PMID: 34649282
- DOI: 10.1093/eurheartj/ehab670
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Erratum for
-
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Eur Heart J. 2021. PMID: 34447992 No abstract available.
Similar articles
-
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):523. doi: 10.1016/j.rec.2022.05.005. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35636830 English, Spanish. No abstract available.
-
[2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC].G Ital Cardiol (Rome). 2022 Apr;23(4 Suppl 1):e1-e127. doi: 10.1714/3777.37630. G Ital Cardiol (Rome). 2022. PMID: 35373785 Italian. No abstract available.
-
Correction to: 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J. 2024 Jan 1;45(1):53. doi: 10.1093/eurheartj/ehad613. Eur Heart J. 2024. PMID: 37995350 No abstract available.
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur J Heart Fail. 2008 Oct;10(10):933-89. doi: 10.1016/j.ejheart.2008.08.005. Epub 2008 Sep 16. Eur J Heart Fail. 2008. PMID: 18826876 Review. No abstract available.
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. Eur Heart J. 2008. PMID: 18799522 Review. No abstract available.
Cited by
-
Time course of remnant cholesterol and the risk of heart failure.Endocrine. 2024 Sep 21. doi: 10.1007/s12020-024-04028-3. Online ahead of print. Endocrine. 2024. PMID: 39306642
-
Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations.Front Cardiovasc Med. 2024 Feb 7;11:1340708. doi: 10.3389/fcvm.2024.1340708. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38385136 Free PMC article. Review.
-
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction.Clin Res Cardiol. 2023 Jan;112(1):167-174. doi: 10.1007/s00392-022-02124-w. Epub 2022 Nov 29. Clin Res Cardiol. 2023. PMID: 36443599 Free PMC article.
-
Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety.ESC Heart Fail. 2023 Apr;10(2):808-823. doi: 10.1002/ehf2.14249. Epub 2022 Nov 29. ESC Heart Fail. 2023. PMID: 36444868 Free PMC article. Review.
-
Unexpected Genetic Twists in Patients with Cardiac Devices.J Clin Med. 2024 Jun 28;13(13):3801. doi: 10.3390/jcm13133801. J Clin Med. 2024. PMID: 38999368 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources